NCT00936624

Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma

A 12 Week, Multi-center,Randomized, Double Blinded, Parallel Group, Placebo-controlled, 4-arm, Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 245 (actual)
• Sponsor: SK Chemicals Co., Ltd. · Industry
• Sex: All
• Age: 15 Years
• Healthy volunteers: Not accepted

Summary

This study is a dose finding trial to assess the efficacy and safety of SOTB07 in persistent asthma.

Detailed description

A 12 week, Multi-center, Randomized, Double blinded, Parallel group, Placebo-controlled, 4-arm, Dose finding trial to Assess the Efficacy and Safety of SOTB07 in persistent asthma.

Conditions

• Asthma

Interventions

Type	Name	Description
DRUG	SOTB07	SOTB07 100mg
DRUG	SOTB07	SOTB07 200mg
DRUG	placebo	placebo
DRUG	montelukast	montelukast 10mg po, bid, 12week

Timeline

• Start date: 2009-07-01
• Primary completion: 2011-05-01
• Completion: 2011-05-01
• First posted: 2009-07-10
• Last updated: 2013-12-19

Locations

1 site across 1 country: South Korea